THE AIDS drug zidovudine can retard the transmission of the AIDS-causing human immunodeficiency virus (HIV) from a mother to her foetus, a recent study reveals (Journal of the American Medical Association, Vol 271, No 11).
Trials carried out by the US-based National Institute of Allergy and Infectious Diseases (NIAID) show that of the 53 newborn children who tested positive for HIV, only 13 were born to women on zidovudine, the rest to women on placebos.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.